{"id":"W2784438562","doi":"10.1016/j.kisu.2017.10.010","title":"Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project","year":2018,"lang":"en","type":"review","venue":"Kidney International Supplements","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University of British Columbia; St. Michael's Hospital; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Sandoz; Sanofi Australia; Amgen; Hospira; International Society of Nephrology; Baxter Healthcare Corporation; Fresenius Medical Care North America; Shire; AstraZeneca; Baxter International; GlaxoSmithKline; Genentech; Department of Biotechnology, Ministry of Science and Technology, India; National Institutes of Health; Medtronic; AbbVie; Abbott Laboratories","keywords":"Medicine; Kidney disease; Health care; Developing country; Global health; Population; Environmental health; Family medicine; Public health; Intensive care medicine; Internal medicine; Economic growth; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527029,0.0006600489,0.001794047,0.003828157,0.0002203776,0.001193027,0.0008359031,0.000735083,0.003457619],"category_scores_gemma":[0.005358722,0.0002607951,0.002244127,0.009219619,0.0003255333,0.001615725,0.001431629,0.001276249,0.0003898687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001416781,"about_ca_system_score_gemma":0.005051797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01886573,"about_ca_topic_score_gemma":0.03388501,"domain_scores_codex":[0.9990768,0.0001811112,0.0002397886,0.0001226289,0.0003005292,0.0000791913],"domain_scores_gemma":[0.9980642,0.001047646,0.000490996,0.00002755592,0.0002741943,0.00009527136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003287156,0.00006359299,0.01157949,0.1178812,0.003255764,0.000164231,0.0003354469,0.0004974304,0.0001542759,0.003337732,0.06579801,0.7966042],"study_design_scores_gemma":[0.0001835876,0.0001455505,0.07676322,0.1617725,0.01183992,0.001110065,0.001207803,0.0002419507,0.0002862771,0.003619546,0.7427004,0.0001291566],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006891176,0.9965166,0.0000520208,0.0009811795,0.0001269586,0.000008401114,0.0009582742,0.000005738763,0.0006616031],"genre_scores_gemma":[0.004207938,0.9946297,0.0001337115,0.0004125907,0.0000797273,0.00001239407,0.000443942,0.000001837916,0.00007809364],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01886573,"threshold_uncertainty_score":0.03751183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03187094360162396,"score_gpt":0.3920909163257212,"score_spread":0.3602199727240973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}